Kiniksa Pharmaceuticals International, plc

KNSA ·Healthcare, Drug Manufacturers - General
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $580.6M

Liabilities Breakdown FY2024

Total Liabilities: $142.1M